Quantum Genomics achieves positive Phase IIa trial top-line results of QGC001 in treating hypertension

French-based bio-pharmaceutical company Quantum Genomics has reported positive top-line data from its Phase IIa trial of QGC001 to treat hypertension (high blood pressure).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news